Ionis Pharmaceuticals at TIDES Europe 2026
Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website
Ionis Pharmaceuticals takes part in 2 sessions at TIDES Europe 2026 in Amsterdam. Its sessions focus on oligonucleotide CMC, from regulatory strategy and health authority interactions to manufacturing. It also describes progress toward a greener SPOS process.
| Organization | TIDES Europe 2026 Attendance |
|---|---|
Ionis Pharmaceuticals Carlsbad, CA | |
Develops and markets antisense oligonucleotide medicines for neurological, cardiometabolic and rare diseases. | Talk Wed Nov 4 08:35–09:05 Regulatory CMC Strategies and Health Authority Interactions for Oligonucleotide Programs How manufacturing and quality filings for antisense drugs differ between the US and other regions, drawn from recent commercial applications. Talk Thu Nov 5 08:35–09:05 Moving Towards a Greener SPOS Process Practical ways to cut the environmental cost of oligonucleotide synthesis, including smaller wash volumes, new column designs and recycled solvent. |
Instantly find 20 buyers from Ionis Pharmaceuticals
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or TIDES Europe. Submit a correction